Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions
暂无分享,去创建一个
Jonathan Dushoff | David J D Earn | Raluca Eftimie | J. Dushoff | D. Earn | R. Eftimie | J. Bramson | B. Bridle | Jonathan L Bramson | Byram W Bridle
[1] F. Celada,et al. IFN-Induced Attrition of CD8 T Cells in the Presence or Absence of Cognate Antigen during the Early Stages of Viral Infections1 , 2006, The Journal of Immunology.
[2] Eleanor Pullenayegum,et al. Potentiating cancer immunotherapy using an oncolytic virus. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] J. Harty,et al. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. , 2000, Science.
[4] J. R. Pomerening,et al. Uncovering mechanisms of bistability in biological systems. , 2008, Current opinion in biotechnology.
[5] R. Vile,et al. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus. , 2007, Cancer research.
[6] Jung-Han Kimn,et al. Optimization of Virotherapy for Cancer , 2010, Bulletin of mathematical biology.
[7] H. Atkins,et al. Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] H. Pircher,et al. Solid tumors “melt” from the inside after successful CD8 T cell attack , 2006, European journal of immunology.
[9] D. Kirschner,et al. Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.
[10] R. M. Hendry,et al. Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice , 2007, Journal of Virology.
[11] I B Schwartz,et al. Bi-instability as a precursor to global mixed-mode chaos. , 1999, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.
[12] Benedetto Piccoli,et al. Determination of the optimal therapeutic protocols in cancer immunotherapy. , 2007, Mathematical biosciences.
[13] A. Barr. REALLOCATION OF RESOURCES , 1976, The Lancet.
[14] Ueda,et al. Safe, explosive, and dangerous bifurcations in dissipative dynamical systems. , 1994, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.
[15] Iram Gleria,et al. Periodic solutions and chaos in a non-linear model for the delayed cellular immune response , 2004 .
[16] L. Perko. Differential Equations and Dynamical Systems , 1991 .
[17] Eduardo Sontag,et al. Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] Mark A. J. Chaplain,et al. Oscillations and bistability in the dynamics of cytotoxic reactions mediated by the response of immune cells to solid tumours , 2008, Math. Comput. Model..
[19] Z Bajzer,et al. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus , 2009, Cancer Gene Therapy.
[20] W. Tabachnick,et al. Influence of Nonsystemic Transmission on the Epidemiology of Insect Borne Arboviruses: A Case Study of Vesicular Stomatitis Epidemiology in the Western United States , 2002, Journal of medical entomology.
[21] D. Turner,et al. Persistent Antigen Presentation after Acute Vesicular Stomatitis Virus Infection , 2006, Journal of Virology.
[22] H. Atkins,et al. Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses. , 2010, Cytokine & growth factor reviews.
[23] Pejman Rohani,et al. Dynamics of infectious diseases and pulse vaccination: Teasing apart the embedded resonance effects , 2006 .
[24] Tilman Brummer,et al. Feedback regulation of lymphocyte signalling , 2004, Nature Reviews Immunology.
[25] Simon Wain-Hobson. Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.
[26] F. Allgöwer,et al. Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis* , 2004, Journal of Biological Chemistry.
[27] Jianjun Paul Tian,et al. Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. , 2006, Cancer research.
[28] L Billings,et al. Exciting chaos with noise: unexpected dynamics in epidemic outbreaks , 2002, Journal of mathematical biology.
[29] J. Boudreau,et al. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] Svetlana Bunimovich-Mendrazitsky,et al. Mathematical Model of BCG Immunotherapy in Superficial Bladder Cancer , 2007, Bulletin of mathematical biology.
[31] B. Benacerraf,et al. Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. , 1960, Journal of immunology.
[32] Joseph J. Hale,et al. From Disorder to Order in Marching Locusts , 2006, Science.
[33] Rustom Antia,et al. Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.
[34] D. Earn,et al. A simple model for complex dynamical transitions in epidemics. , 2000, Science.
[35] R. Alemany,et al. Blood clearance rates of adenovirus type 5 in mice. , 2000, The Journal of general virology.
[36] D. Earn,et al. Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.
[37] I B Schwartz,et al. Infinite subharmonic bifurcation in an SEIR epidemic model , 1983, Journal of mathematical biology.
[38] M. L. Martins,et al. A multiscale mathematical model for oncolytic virotherapy. , 2009, Cancer research.
[39] Helen M. Byrne,et al. Macrophage-tumour interactions: in vivo dynamics , 2003 .
[40] Alan S. Perelson,et al. Recruitment Times, Proliferation, and Apoptosis Rates during the CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.
[41] Zeljko Bajzer,et al. Modeling of cancer virotherapy with recombinant measles viruses. , 2008, Journal of theoretical biology.
[42] B. Spagnolo,et al. Monitoring noise-resonant effects in cancer growth influenced by external fluctuations and periodic treatment , 2007, 0710.1317.
[43] P. Marrack,et al. Homeostasis of the Memory T Cell Pool , 2005, International Archives of Allergy and Immunology.
[44] L. Wein,et al. Analysis of a three-way race between tumor growth, a replication-competent virus and an immune response , 2004, Bulletin of mathematical biology.
[45] A. Weinberg,et al. 4‐1BB and OX40 stimulation enhance CD8 and CD4 T‐cell responses to a DNA prime, poxvirus boost vaccine , 2004, Immunology.
[46] W Horsthemke,et al. Bistability in fluctuating environments. Implications in tumor immunology. , 1979, Bulletin of mathematical biology.
[47] J. Allison,et al. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors , 2010, Proceedings of the National Academy of Sciences.
[48] K. Tanabe,et al. Viral oncolysis. , 2002, The oncologist.
[49] G. Dock. The Influence Of Complicating Diseases Upon LeukÆmia. , 1904 .
[50] R. Parks,et al. Persistence of Transgene Expression Influences CD8+ T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus , 2009, Journal of Virology.
[51] Lawrence M Wein,et al. Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. , 2003, Cancer research.
[52] H. Pircher,et al. On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[53] Dominik Wodarz,et al. Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection , 2009, PloS one.
[54] J. Libnoch,et al. Remission of chronic lymphocytic leukemia after smallpox vaccination. , 1978, Archives of internal medicine.
[55] D L S McElwain,et al. A history of the study of solid tumour growth: The contribution of mathematical modelling , 2004, Bulletin of mathematical biology.
[56] M. L. Martins,et al. Fighting cancer with viruses , 2005 .
[57] R. M. Hendry,et al. Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. , 2004, AIDS research and human retroviruses.
[58] A. Meshorer,et al. Involvement of interferon in virus-induced lymphopenia. , 1983, Cellular immunology.
[59] Susan M. Kaech,et al. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .
[60] A. Bluming,et al. Regression of Burkitt's lymphoma in association with measles infection. , 1971, Lancet.
[61] Antonio Lanzavecchia,et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.
[62] D. Wodarz,et al. Viruses as antitumor weapons: defining conditions for tumor remission. , 2001, Cancer research.
[63] Hannah H. Chang,et al. Multistable and multistep dynamics in neutrophil differentiation , 2006, BMC Cell Biology.
[64] W. Yokoyama,et al. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. , 2007, Cancer research.